https://scholars.lib.ntu.edu.tw/handle/123456789/582032| Title: | APASL consensus statements and management algorithms for hepatitis C virus infection | Authors: | Omata M. Kanda T. Yu M.-L. Yokosuka O. Lim S.-G. Jafri W. Tateishi R. Hamid S.S. Chuang W.-L. Chutaputti A. Wei L. Sollano J. Sarin S.K. JIA-HORNG KAO McCaughan G.W. |
Keywords: | APASL; DAAs; Guideline; HCV; Treatment | Issue Date: | 2012 | Journal Volume: | 6 | Journal Issue: | 2 | Start page/Pages: | 409-435 | Source: | Hepatology International | Abstract: | The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the "APASL Consensus Statements and Management Algorithms for Hepatitis C Virus Infection" in December, 2010, in order to revise "Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection (J Gastroenterol Hepatol 22:615-633, 2007)". The working party consisted of expert hepatologists from the Asian-Pacific region gathered at Makuhari, Chiba, Japan on 19 December 2010. New data were presented, discussed and debated to draft a revision. Participants of the consensus meeting assessed the quality of cited studies. Finalized recommendations are presented in this review. ? 2012 Asian Pacific Association for the Study of the Liver. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862850805&doi=10.1007%2fs12072-012-9342-y&partnerID=40&md5=3934cb73e57e378248ae850d523bbd11 https://scholars.lib.ntu.edu.tw/handle/123456789/582032 |
ISSN: | 1936-0533 | DOI: | 10.1007/s12072-012-9342-y | SDG/Keyword: | alisporivir; amantadine; analgesic agent; antidepressant agent; boceprevir; didanosine; erythropoietin; glycyrrhizic acid; granulocyte colony stimulating factor; interferon; interleukin 10; neominophagen C; nonsteroid antiinflammatory agent; ofloxacin; peginterferon alpha; peginterferon alpha2a; peginterferon alpha2a plus ribavirin; peginterferon alpha2b; peginterferon alpha2b plus ribavirin; peptide vaccine; placebo; ribavirin; silibinin; silymarin; telaprevir; thymosin alpha1; unindexed drug; ursodeoxycholic acid; xiao chai hu tang; zidovudine; add on therapy; adjuvant therapy; algorithm; anemia; article; Asia Pacific region; blood donor; blood safety; chronic kidney disease; consensus; diarrhea; disease course; dried blood spot testing; drug contraindication; drug dose reduction; drug eruption; drug withdrawal; dysgeusia; genotyping technique; geographic names; hemodialysis; hemophilia; hepatitis B; hepatitis C; human; Human immunodeficiency virus infection; infection control; injection; intravenous drug abuse; Japan; liver fibrosis; liver transplantation; medical procedures; medical society; medical specialist; nausea; neutropenia; practice guideline; priority journal; pruritus; recommended drug dose; RNA analysis; safe sex; sexual transmission; thalassemia; treatment indication; unspecified side effect; virus transmission [SDGs]SDG3 |
| Appears in Collections: | 臨床醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.